tetano
Editor, Senior Moderator
Am J Transplant. 2020 Apr 3. doi: 10.1111/ajt.15896. [Epub ahead of print]
COVID-19 in post-transplantation patients- report of two cases.
Huang J[SUP]1[/SUP], Lin H[SUP]2[/SUP], Wu Y[SUP]1[/SUP], Fang Y[SUP]3[/SUP], Kumar R[SUP]4[/SUP], Chen G[SUP]5[/SUP], Lin S[SUP]1[/SUP].
Author information
Abstract
Coronavirus Disease 2019 (COVID-19) has become a pandemic since March 2020. We describe here, two cases of COVID-19 infection in a post-transplant setting. First one is a 59-year old renal transplant recipient; the second is a 51-year old allogeneic bone marrow transplant recipient. Both patients were on immunosuppressant therapy and had stable graft function before COVID-19 infection. After the diagnosis of COVID-19, immunosuppressive agents were discontinued and methylprednisolone with prophylactic antibiotics were initiated, however, the lung injury progressed. The T cells were extremely low in both patients after infection. Both patients died despite the maximal mechanical ventilatory support. Therefore, the prognosis of COVID-19 pneumonia following transplantation is not optimistic and remains guarded. Lower T cell count may be a surrogate for poor outcome.
This article is protected by copyright. All rights reserved.
KEYWORDS:
COVID-19; Coronavirus; transplantation
PMID:32243697DOI:10.1111/ajt.15896
COVID-19 in post-transplantation patients- report of two cases.
Huang J[SUP]1[/SUP], Lin H[SUP]2[/SUP], Wu Y[SUP]1[/SUP], Fang Y[SUP]3[/SUP], Kumar R[SUP]4[/SUP], Chen G[SUP]5[/SUP], Lin S[SUP]1[/SUP].
Author information
Abstract
Coronavirus Disease 2019 (COVID-19) has become a pandemic since March 2020. We describe here, two cases of COVID-19 infection in a post-transplant setting. First one is a 59-year old renal transplant recipient; the second is a 51-year old allogeneic bone marrow transplant recipient. Both patients were on immunosuppressant therapy and had stable graft function before COVID-19 infection. After the diagnosis of COVID-19, immunosuppressive agents were discontinued and methylprednisolone with prophylactic antibiotics were initiated, however, the lung injury progressed. The T cells were extremely low in both patients after infection. Both patients died despite the maximal mechanical ventilatory support. Therefore, the prognosis of COVID-19 pneumonia following transplantation is not optimistic and remains guarded. Lower T cell count may be a surrogate for poor outcome.
This article is protected by copyright. All rights reserved.
KEYWORDS:
COVID-19; Coronavirus; transplantation
PMID:32243697DOI:10.1111/ajt.15896